KRISTYN SPENCER: Open Payments
NPI 1144671371 · GLOVERSVILLE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 17 payments from 7 companies in 2025. Trend: 2023 $342 · 2024 $488 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $91 |
| Lilly USA, LLC | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| ABBVIE INC. | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Dexcom, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $21 |
Products named: MOUNJARO, AIRSUPRA, Ozempic, JARDIANCE, Dexcom G6 Transmitter, VRAYLAR, Rybelsus, Wegovy.
Industry payments across NY — which companies pay providers there.
